Integrated untargeted and targeted metabolomics to reveal therapeutic effect and mechanism of Alpiniae oxyphyllae fructus on Alzheimer’s disease in APP/PS1 mice. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.